The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Genome-wide analysis of histone modifications in human pancreatic islets
Open accessAbstract
The global diabetes epidemic poses a major challenge. Epigenetic events contribute to the etiology of diabetes; however, the lack of epigenomic analysis has limited the elucidation of the mechanistic basis for this link. To determine the epigenetic architecture of human pancreatic islets we mapped the genome-wide locations of four histone marks: three associated with gene activation—H3K4me1, H3K4me2, and H3K4me3—and one associated with gene repression, H3K27me3. Interestingly, the promoters of the highly transcribed insulin and glucagon genes are occupied only sparsely by H3K4me2 and H3K4me3. Globally, we identified important relationships between promoter structure, histone modification, and gene expression. We demonstrated co-occurrences of histone modifications including bivalent marks in mature islets. Furthermore, we found a set of promoters that is differentially modified between islets and other cell types. We also use our histone marks to determine which of the known diabetes-associated single-nucleotide polymorphisms are likely to be part of regulatory elements. Our global map of histone marks will serve as an important resource for understanding the epigenetic basis of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies of pancreatic islets from nondiabetic donors ( 19 , 20 ) and patients with T2D ( 21 ) have identified epigenetic modifications in genes that potentially affect β-cell function.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,568
Histone modifications at human enhancers reflect global cell-type-specific gene expression
Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W., et al. (2009) · Nature · doi:10.1038/nature07829 · Cited by 2,533
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R., Chevalier, B. S., Johnstone, S. E., Cole, M. F., Isono, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,296
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267 · cited 2×
“and histone modifications (Cedar and Bergman 2009).”
The UCSC Genome Browser database: update 2011
Fujita, P. A., Rhead, B., Zweig, A. S., Hinrichs, A. S., Karolchik, D., Cline, M., Goldman, M. J., Barber, G. P., Clawson, H., Coelho, A., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq963 · Cited by 1,843
Genomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse
Bernstein, B., Kamal, M., Lindblad‐Toh, K., Bekiranov, S., Bailey, D. K., Huebert, D. J., McMahon, S., Karlsson, E. K., Kulbokas, E. J., Gingeras, T., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.001 · Cited by 1,567
Genome-wide Map of Nucleosome Acetylation and Methylation in Yeast
Pokholok, D., Harbison, C. T., Levine, S. S., Cole, M. F., Hannett, N. M., Lee, T. I., Bell, G. W., Walker, K., Rolfe, A., Herbolsheimer, E., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.026 · Cited by 1,477
Flagged first, then by citations
1 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Epigenetics in Human Obesity and Type 2 Diabetes
Ling, C., & Rönn, T. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.009 · Cited by 1,006
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants
Pasquali, L., Gaulton, K. J., Rodríguez‐Seguí, S. A., Mularoni, L., Miguel-Escalada, I., Akerman, İ., Tena, J. J., Morán, I., Gómez-Marín, C., van de Bunt, M., et al. (2014) · Nature Genetics · doi:10.1038/ng.2870 · Cited by 521
Rivera, C. M., & Ren, B. (2013) · Cell · doi:10.1016/j.cell.2013.09.011 · Cited by 550
β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
“Studies of pancreatic islets from nondiabetic donors (19,20) and patients with T2D (21) have identified epigenetic modifications in genes that potentially affect b-cell function.”
BackgroundVolkmar, M., Dedeurwaerder, S., Cunha, D. A., Ndlovu, M. N., Defrance, M., Deplus, R., Calonne, E., Volkmar, U., Igoillo‐Esteve, M., Naamane, N., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.503 · Cited by 420
“An example of such a study is the work by Bhandare et al (2010) that described gene expression in islets from 31 non-diabetic donors.”
Epigenomic plasticity enables human pancreatic α to β cell reprogramming
Bramswig, N. C., Everett, L. J., Schug, J., Dorrell, C., Liu, C., Luo, Y., Streeter, P. R., Naji, A., Grompe, M., & Kaestner, K. H. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66514 · Cited by 416
“…previous studies have characterized histone methylation signatures, open chromatin sites, and CTCF-binding (CCCTC-binding factor) sites of whole human islets (8–10), cell-type–specific epigenetic signatures and RNA sequencing (RNA-Seq) analysis of human pancreatic cells have not been determined.”
Self-citationYang, B. T., Dayeh, T. A., Volkov, P. A., Kirkpatrick, C. L., Malmgren, S., Jing, X., Renström, E., Wollheim, C. B., Nitert, M. D., & Ling, C. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1004 · Cited by 301
The role of epigenetics in the pathology of diabetic complications
Villeneuve, L. M., & Natarajan, R. D. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00200.2010 · Cited by 299
“A recent epigenomic analysis of histone methylation modifications in human pancreatic islets revealed key relationships with chromatin structure, gene expression, and epigenetic information relevant to diabetes (15).”
BackgroundBell, C. G., Finer, S., Lindgren, C. M., Wilson, G. A., Rakyan, V. K., Teschendorff, A. E., Akan, P., Stupka, E., Down, T. A., Prokopenko, I., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014040 · Cited by 260
“2 kb wide over rs8050136 within the region [55].”
BackgroundXie, R., Everett, L. J., Lim, H., Patel, N. A., Schug, J., KROON, E. J., Kelly, O., Wang, A., D’Amour, K. A., Robins, A. J., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2012.11.023 · Cited by 245
“ChIP-seq Sample Preparation and Analysis Chromatin immunoprecipitations were performed as previously described (Bhandare et al., 2010).”
MethodSelf-citationβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 242
“Studies of pancreatic islets from non-diabetic donors (19, 20) and from patients with T2D (21) have identified epigenetic modifications in genes that potentially affect β-cell function.”
BackgroundStitzel, M. L., Sethupathy, P., Pearson, D. S., Chines, P. S., Song, L., Erdos, M. R., Welch, R., Parker, S. C. J., Boyle, A. P., Scott, L. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.012 · Cited by 193
“Also, extensive chromatin profiling has been conducted in very few human primary tissues to date (Bhandare et al., 2010).”
PBX1 Genomic Pioneer Function Drives ERα Signaling Underlying Progression in Breast Cancer
Magnani, L., Ballantyne, E. B., Zhang, X., & Lupien, M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002368 · Cited by 198
“Furthermore, cell type-specific distribution of the mono and di-methylated H3K4 (H3K4me1 and me2) epigenetic modifications are central to cell type-specific transcriptional responses [6,59,60].”
BackgroundVavouri, T., & Lehner, B. (2012) · Genome biology · doi:10.1186/gb-2012-13-11-r110 · Cited by 138
“Consistent with this, unmethylated CpG promoters have higher levels of H3K4me3, a histone modification associated with transcription initiation [24-27].”
BackgroundEpigenetics of type 2 diabetes mellitus and weight change — a tool for precision medicine?
Ling, C., Bacos, K., & Rönn, T. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00671-w · Cited by 138
Bahar Halpern, K., Vana, T., & Walker, M. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573469 · Cited by 119
“In the case of FoxA2, this possibility is more likely because in genome-wide chromatin state analysis done in human pancreatic islets (42), there is some evidence for such an upstream enhancer according to the presence of H3K4me around the CpG1 region.”
BackgroundDNA Methylation as a Diagnostic and Therapeutic Target in the Battle Against Type 2 Diabetes
Rönn, T., & Ling, C. (2015) · Epigenomics · doi:10.2217/epi.15.7 · Cited by 110
Epigenetic Modifications in the Pathogenesis of Diabetic Nephropathy
Reddy, M. A., Park, J. T., & Natarajan, R. D. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.05.006 · Cited by 100
Emerging roles of non‐coding RNAs in pancreatic β‐cell function and dysfunction
Guay, C., Jacovetti, C., Nesca, V., Motterle, A., Tugay, K., & Regazzi, R. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01654.x · Cited by 88
Dominant Form of Congenital Hyperinsulinism Maps to HK1 Region on 10q
Pinney, S. E., Ganapathy, K., Bradfield, J. P., Stokes, D., Sasson, A., Mackiewicz, K., Boodhansingh, K. E., Hughes, N., Becker, S. A., Givler, S., et al. (2013) · Hormone Research in Paediatrics · doi:10.1159/000351943 · Cited by 83
Epigenetics of chronic inflammatory diseases
Stylianou, E. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s129027 · Cited by 79
“Furthermore, distinct combinations of methylated H3 proteins were associated with different promoters.(65) Highly expressed genes, such as insulin and glucagon, were marked by very low levels of H3K4me3 indicating that other epigenetic modifications may regulate these genes.”
BackgroundAnnotation of chromatin states in 66 complete mouse epigenomes during development
van der Velde, A., Fan, K., Tsuji, J., Moore, J. E., Purcaro, M. J., Pratt, H., & Weng, Z. (2021) · Communications Biology · doi:10.1038/s42003-021-01756-4 · Cited by 68
Lin, B., Lee, H., Yoon, J.-G., Madan, A., Wayner, E. A., Tonning, S., Hothi, P., Schroeder, B., Ulasov, I. V., Foltz, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3030 · Cited by 76
“For example, GAPDH was enriched 157-fold in the H3K4me3 ChIP from the SN186 GSC cell line versus the IgG control ChIP (Figure 1A).”
BackgroundMalmgren, S., Spégel, P., Danielsson, A. P. H., Nagorny, C. L., Andersson, L. E., Nitert, M. D., Ridderstråle, M., Mulder, H., & Ling, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.422527 · Cited by 71
Low, F. M., Gluckman, P. D., & Hanson, M. A. (2011) · Epigenomics · doi:10.2217/epi.11.17 · Cited by 71
The epigenomic interface between genome and environment in common complex diseases
Bell, C. G., & Beck, S. (2010) · Briefings in Functional Genomics · doi:10.1093/bfgp/elq026 · Cited by 64
“Analysis of common histone marks, also in human pancreatic islets, detected regulatory elements in the location of known T2D SNP associations [63].”
Stem cell approaches for diabetes: towards beta cell replacement
Weir, G. C., Cavelti‐Weder, C., & Bonner‐Weir, S. (2011) · Genome Medicine · doi:10.1186/gm277 · Cited by 60
“Chromatin immunoprecipitation and parallel sequencing (ChiP-seq) technology has been used to study histone marks in human islets [23].”
MethodPathways governing development of stem cell‐derived pancreatic β cells: lessons from embryogenesis
Al‐Khawaga, S., Memon, B., Butler, A. E., Taheri, S., Abou‐Samra, A., & Abdelalim, E. M. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12349 · Cited by 59
“…methylation for adult human islets revealed that hormone-specific promoters like glucagon and insulin do not possess high enrichment of activating H3K4Me3 mark implying that other epigenetic mechanisms are responsible for their activation in the respective mature islets (Bhandare et al., 2010).”
BackgroundKoufariotis, L. T., Chen, Y. P., Bolormaa, S., & Hayes, B. J. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-436 · Cited by 59
“While regions of the genome associated with histone modification patterns have been shown to influence gene expression, and to be enriched for TAVs [22,24].”
BackgroundMethodTissue-specific regulation of mouse MicroRNA genes in endoderm-derived tissues
Gao, Y. P., Schug, J., McKenna, L. B., Lay, J. E. L., Kaestner, K. H., & Greenbaum, L. E. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq782 · Cited by 53
Self-citationNeonatal monocytes exhibit a unique histone modification landscape
Bermick, J., Lambrecht, N., denDekker, A. D., Kunkel, S. L., Lukacs, N. W., Hogaboam, C. M., & Schaller, M. A. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0265-7 · Cited by 52
“This may reflect the conversion of H3K4me1 to H3K4me3 through the intermediate H3K4me2 rather than a complete loss or gain of histone methylation at these sites [33, 34].”
BackgroundSandovici, I., Hammerle, C. M., Ozanne, S. E., & Constância, M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1297-1 · Cited by 52
“Another study used global distribution mapping of H3K4me1 in human islets (a histone modification that has been found to mark active enhancers and promoters [55]), and reported on approximately 35,000 intergenic peaks [49].”
Epigenetic modifications in pancreas development, diabetes, and therapeutics
Kaimala, S., Kumar, C. A., Allouh, M. Z., Ansari, S. A., & Emerald, B. S. (2022) · Medicinal Research Reviews · doi:10.1002/med.21878 · Cited by 53
“Identification of T2D‐associated single‐nucleotide polymorphisms (SNPs) mapping to these enhancers further fortifies their argument of enhancer‐mediated regulation of islet‐specific hormones.38 Bhandare et al.39 also observed significantly low levels of H3K4me2 and me3 at the promoters of INS and glucagon (GCG) in hum…”
BackgroundInfluentialEpigenetic modifications and long noncoding RNAs influence pancreas development and function
Arnes, L., & Sussel, L. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.02.008 · Cited by 54
The Pancreatic Islet Regulome Browser
Mularoni, L., Ramos-Rodríguez, M., & Pasquali, L. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00013 · Cited by 49
The genomic signature of trait-associated variants
Kindt, A. S. D., Navarro, P., Semple, C. A. M., & Haley, C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-108 · Cited by 46
“Studies focusing on the epigenomic landscape, such as DNA methylation [11] and histone modification patterns [12] surrounding the variants have shown SNPs and DNA modifications jointly influencing transcription of nearby genes.”
BackgroundWesolowska‐Andersen, A., Yu, G. Z., Nylander, V., Abaitua, F., Thurner, M., Torres, J., Mahajan, A., Gloyn, A. L., & McCarthy, M. I. (2020) · eLife · doi:10.7554/elife.51503 · Cited by 46
Epigenetics and diabetes treatment: an unrealized promise?
Bramswig, N. C., & Kaestner, K. H. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.02.002 · Cited by 45
“These studies were able to characterize open chromatin sites [35], the mono-, di- and trimethylation profile of histone 3 (including the H3K4me1, H3K4me2, H3K4me3, H3K27me3, and H3K79me2 marks), and the binding sites of CTCF (CCCTC-binding factor), an important epigenetic regulator [36], in human islets [37, 38].”
BackgroundSelf-citationDayeh, T., & Ling, C. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0057 · Cited by 41
“In addition, some variants were found in H3K27me3-enriched regions and were suggested to regulate glucose homeostasis in other tissues or cause local disruption of the H3K27me3 distribution in islets (Bhandare et al. 2010).”
Epigenome-Wide Association Studies (EWAS) in Cancer
Verma, M. (2012) · Current Genomics · doi:10.2174/138920212800793294 · Cited by 42
“In another study, genome-wide histone mapping was completed in type 2 diabetes [32].”
BackgroundBrd2 Gene Disruption Causes “Metabolically Healthy” Obesity
Wang, F., Deeney, J. T., & Denis, G. V. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00003-1 · Cited by 41
“…islets, histone lysine methylation patterns have been identified that define transcriptionally " primed " as well as transcriptionally active promoters (Bhandare et al., 2010), but this vein of research is relatively underdeveloped, compared to the study of histone lysine methylation in cancer.”
BackgroundFunctional implications of long non-coding RNAs in the pancreatic islets of Langerhans
Esguerra, J. L. S., & Eliasson, L. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00209 · Cited by 41
Durning, S. P., Flanagan‐Steet, H. R., Prasad, N., & Wells, L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.693580 · Cited by 40
“This has been previously observed when investigating genome-wide histone modifications in human pancreatic islets and may be true for the more homologous mouse Ins2 gene [43].”
BackgroundSymmank, J., Bayer, C., Schmidt, C., Hahn, A., Pensold, D., & Zimmer‐Bensch, G. (2018) · Epigenetics · doi:10.1080/15592294.2018.1475980 · Cited by 41
“A promoter region in the Gapdh gene locus was used to validate the method, as Gapdh is often associated with H3K4me3 [67,68].”
MethodThe pancreatic β cell: recent insights from human genetics
Thomsen, S. K., & Gloyn, A. L. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.05.001 · Cited by 38
Epigenetic control of β-cell function and failure
Bernstein, D., Golson, M. L., & Kaestner, K. H. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.11.009 · Cited by 38
“In some cases, they occur because of changes in gene regulatory sequences, such as those that alter transcription factor binding of islet enhancers [92, 93] or which add CpGs that can contribute to gene silencing [94].”
Self-citationGerasimova, A. V., Chávez, L., Li, B., Seumois, G., Greenbaum, J., Rao, A., Vijayanand, P., & Peters, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054359 · Cited by 35
“Notably, the location of enhancers is highly cell-type specific [28], supporting the notion that different cell types maintain their specialized functions by selectively activating different regulatory regions of the genome [29].”
BackgroundThe metabolic-epigenetic nexus in type 2 diabetes mellitus
Davison, G. W., Irwin, R. E., & Walsh, C. P. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.025 · Cited by 35
Chromatin Regulators in Pancreas Development and Diabetes
Campbell, S. A., & Hoffman, B. G. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.12.005 · Cited by 34
Epigenetic regulation of inflammation: The metabolomics connection
Rath, S., Hawsawi, Y. M., Alzahrani, F. A., & Khan, M. I. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.09.008 · Cited by 34
Implication of epigenetics in pancreas development and disease
Quilichini, E., & Haumaître, C. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.10.010 · Cited by 35
Nutrients and the Pancreas: An Epigenetic Perspective
Weisbeck, A., & Jansen, R. J. (2017) · Nutrients · doi:10.3390/nu9030283 · Cited by 34
“Within human pancreatic islets cells, histone modifications have been associated with activation or repression of genes [70].”
BackgroundUncovering the gene regulatory network of type 2 diabetes through multi-omic data integration
Liu, J., Liu, S., Yu, Z., Qiu, X., Jiang, R., & Li, W. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03826-5 · Cited by 34
“The modification of H3K4me3 in pancreatic islets was confirmed to depend on the presence of CpG [20], which explains our result that CTCF binds near the chromatin region occupied by H3K4me3.”
Kuo, T., Damle, M., González, B. J., Egli, D. M., Lazar, M. A., & Accili, D. (2019) · JCI Insight · doi:10.1172/jci.insight.128351 · Cited by 32
Epigenetic regulation of pancreas development and function
Avrahami, D., & Kaestner, K. H. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.06.002 · Cited by 33
“The first genome-wide epigenetic studies of human pancreatic islets, using chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-Seq analysis), focused on characterizing histone modifications that are involved in gene activation and repression such as H3K4me1, H3K4me2, H3K4me3, H3K79me2 and H3K27m…”
BackgroundSelf-citationThe Epigenome and Its Role in Diabetes
Waki, H., Yamauchi, T., & Kadowaki, T. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0328-x · Cited by 31
“also conducted comprehensive epigenomic analyses in human pancreatic islets and showed that a substantial number of diabetes-associated non-coding SNPs are located in H3K4me1-enriched enhancer-like regions [95].”
Background“Omics” and “epi-omics” underlying the β-cell adaptation to insulin resistance
Jesus, D. F. D., & Kulkarni, R. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.003 · Cited by 33
“Furthermore, mature islets show bivalent histone markers and insulin and glucagon promoters show very low levels of H3K4me3 in contrast to genes like PDX1 and MAFB [49].”
BackgroundEpigenetic Regulation of β Cell Identity and Dysfunction
Sun, X., Wang, L., Obayomi, S. M. B., & Wei, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.725131 · Cited by 32
Epigenetics and diabetic cardiomyopathy
Singh, G. B., Sharma, R., & Khullar, M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.033 · Cited by 28
“Altered histone methylation patterns have been also observed to be associated with chromatin structure, gene expression in human pancreatic islets [30].”
BackgroundWarburton, A., Miyajima, F., Shazadi, K., Crossley, J., Johnson, M. R., Marson, A. G., Baker, G. A., Quinn, J. P., & Sills, G. J. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.11.013 · Cited by 28
Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus
Hossan, T., Kundu, S., Alam, S. S., & Nagarajan, S. (2019) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530319666190301145545 · Cited by 33
Pancreatic progenitor epigenome maps prioritize type 2 diabetes risk genes with roles in development
Geusz, R. J., Wang, A., Chiou, J., Lancman, J. J., Wetton, N., Kefalopoulou, S., Wang, J., Qiu, Y., Yan, J., Aylward, A., et al. (2021) · eLife · doi:10.7554/elife.59067 · Cited by 25
Non-coding genome functions in diabetes
Cebola, I., & Pasquali, L. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0197 · Cited by 25
Moreno‐Asso, A., Castaño, C., Grilli, A., Novials, A., & Servitja, J. (2013) · Diabetologia · doi:10.1007/s00125-013-2930-0 · Cited by 24
“The identity of beta cells is defined during pancreatic development by epigenetic mechanisms that ensure the appropriate activation and repression of genes in beta cells [3–5].”
Epigenetics in β-cell adaptation and type 2 diabetes
Kim, H., & Kulkarni, R. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.10.008 · Cited by 22
Wang, L. Y., Wang, P., Li, M. J., Qin, J., Wang, X., Zhang, M. Q., & Wang, J. (2011) · Epigenetics · doi:10.4161/epi.6.12.18176 · Cited by 21
“19 Through the resulting network and heatmap pages, we observed several phenomena that were consistent with those reported in Bhandare et al. 19 First, all the four histone modification marks were significant in regulating gene expression (p < 0.05, Fig.”
InfluentialGenome-wide association study identifies novel type II diabetes risk loci in Jordan subpopulations
Dajani, R. B., Li, J., Wei, Z., March, M., Xia, Q., Khader, Y. S., Hakooz, N., Fatahallah, R., El-Khateeb, M. S., Arafat, A., et al. (2017) · PeerJ · doi:10.7717/peerj.3618 · Cited by 22
“3) and 267 additional T2D relevant cell lines (Supplementary Table 3) (Bhandare et al. 2010; Encode 268 Project Consortium 2012; Parker et al. 2013; Pasquali et al. 2014; Roadmap Epigenomics et al. 269 2015).”
BackgroundProfiling of Embryonic Stem Cell Differentiation
Shiraki, N., Ogaki, S., & Kume, S. (2014) · The Review of Diabetic Studies · doi:10.1900/rds.2014.11.102 · Cited by 19
“H3K27me3 is enriched in genes that are repressed by polycomb (PcG) proteins.”
BackgroundInfluentialDavid, S.-A., Piégu, B., Hennequet‐Antier, C., Pannetier, M., Aguirre-Lavin, T., Crochet, S., Bordeau, T., Couroussé, N., Brionne, A., Bigot, Y., et al. (2017) · Biological Procedures Online · doi:10.1186/s12575-017-0059-0 · Cited by 19
“Three regions were selected based on the literature, two of them known to be enriched for the H3K27me3 mark in myotubes and myoblasts (SOX2 and PAX5 [25]) and one known to display low levels of enrichment (GAPDH [27]).”
MethodNeuronal Lhx1 expression is regulated by DNMT1-dependent modulation of histone marks
Symmank, J., Bayer, C., Reichard, J., Pensold, D., & Zimmer‐Bensch, G. (2020) · Epigenetics · doi:10.1080/15592294.2020.1767372 · Cited by 19
“[35] Bhandare R, Schug J, Le Lay J, et al.”
BackgroundMethodNozaki, T., Yachie, N., Ogawa, R., Kratz, A., Saito, R., & Tomita, M. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-416 · Cited by 15
Salam, M. T. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-8603-9_11 · Cited by 15
Detection of type 2 diabetes related modules and genes based on epigenetic networks
Liu, H., Wang, T., Liu, H., Wei, Y., Zhao, G., Su, J., Wu, Q., Qiao, H., & Zhang, Y. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-s1-s5 · Cited by 14
“A map of histone modifications for human islet tissue was constructed by ChIP-seqencing (ChIPseq), including the active (H3K4me1, H3K4me2 and H3K4me3) and inhibitive (H3K27me3) histone modifications, which was considered as the reference to the researches for the T2D etiology [18].”
BackgroundNovel Pancreatic Endocrine Maturation Pathways Identified by Genomic Profiling and Causal Reasoning
Gutteridge, A., Rukstalis, J. M., Ziemek, D., Tié, M., Ji, L., Ramos-Zayas, R., Nardone, N. A., Norquay, L., Brenner, M. B., Tang, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056024 · Cited by 14
“Outside the context of directed differentiation, mature mammalian beta cells and islets have also been extensively profiled at the epigenetic [12–14], miRNA [15–17], protein [18] and gene expression levels [19–22].”
BackgroundAyan, E. B., & DeMi̇rci̇, H. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220610150342 · Cited by 14
Mawla, A. M., van der Meulen, T., & Huising, M. O. (2023) · BMC Genomics · doi:10.1186/s12864-023-09293-6 · Cited by 14
“Previous studies have explored pancreatic islet cellular identity by evaluating epigenomic features such as methylation [12-14], histone modifications [15-18], and enhancer regulatory”
BackgroundEpigenetic Regulation of Pancreatic Islets
Haumaître, C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0403-y · Cited by 14
“Moreover, findings obtained with combination of DNaseand ChIP-seq approaches present a global map of the human islet epigenome and should provide functional context for noncoding variants emerging from genetic studies of diabetes and other islet disorders [20, 21].”
BackgroundEufrásio, A., Perrod, C., Ferreira, F. J., Duque, M., Galhardo, M., & Bessa, J. (2020) · Diabetes · doi:10.2337/db19-1049 · Cited by 15
Transcriptional and epigenetic regulation in human islets
Bramswig, N. C., & Kaestner, K. H. (2013) · Diabetologia · doi:10.1007/s00125-013-3150-3 · Cited by 12
“This technique was performed for the profiling of different histone modifications, such as H3K4me3, H3K27me3, H3K4me1 and H3K79me2, as well as CCCTC factor (CTCF) binding sites in whole human islets [22, 23].”
MethodSelf-citationTranscriptional Regulation of the Pancreatic Islet: Implications for Islet Function
Stitzel, M. L., Kycia, I., Kursawe, R., & Ucar, D. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0635-0 · Cited by 13
“Data from multiple groups suggest that these promoters are not highly enriched for the typical punctate H3K4me3 active promoter mark despite the genes being highly expressed [39], [43], [47].”
InfluentialLam, V. K. L., Ronald, C. W., Lee, H. M., Hu, C., Park, K. S., Furuta, H., Wang, Y., Tam, C. H. T., Sim, X., Ng, D. P. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062378 · Cited by 11
“Regulation of gene expression (epigenetics) is a complex process involving chromatin and histone modifications which play pivotal roles in determining cellular structure and function [20,21,32].”
BackgroundOrganogenesis and functional genomics of the endocrine pancreas
Bramswig, N. C., & Kaestner, K. H. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0915-z · Cited by 12
“This allows for the identification of gene regulatory networks; for example, those that control development and function of the endocrine pancreas, and their epigenetic regulation [18, 19].”
BackgroundInfluentialSelf-citationLiang, X., Duan, H., Mao, Y., Koestner, U., Wei, Y., Deng, F. M., Zhuang, J., Li, H., Wang, C., Hernandez-Miranda, L. R., et al. (2021) · Diabetes · doi:10.2337/db20-0883 · Cited by 11
Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications
Togliatto, G., Dentelli, P., & Brizzi, M. F. (2015) · Journal of Diabetes Research · doi:10.1155/2015/373708 · Cited by 11
“In this sense, epigenomic analysis in human pancreatic islets shows a strict association with gene expression and histone modification and is possibly relevant to diabetes [77].”
mTORC1 is required for epigenetic silencing during β-cell functional maturation
Ni, Q., Sun, J., Wang, Y., Wang, Y., Liu, J., Ning, G., Wang, W., & Wang, Q. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101559 · Cited by 10
“A growing body of evidence suggests that epigenetic regulations, such as DNA methylation [10,33,34], histone modifications (H3K4me3 [35], H3K27me3 [23,25], HDACs [36]) and MicroRNAs [11], are tightly linked to b-cell identity and maturity.”
BackgroundEvidence for sequence biases associated with patterns of histone methylation
Wang, Z., & Willard, H. F. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-367 · Cited by 11
“© 2012 Wang and Willard; licensee BioMed Ce Creative Commons Attribution License (http:/ distribution, and reproduction in any medium relate such maps to cellular phenotypes in organisms from yeast to human [9-11].”
BackgroundFunctional annotation of sixty-five type-2 diabetes risk SNPs and its application in risk prediction
Wu, Y., Jing, R., Dong, Y., Kuang, Q., Li, Y., Huang, Z., Gan, W., Xue, Y., Li, M., & Li, M. (2017) · Scientific Reports · doi:10.1038/srep43709 · Cited by 14
Translational implications of the β-cell epigenome in diabetes mellitus
Johnson, J. S., & Evans‐Molina, C. (2014) · Translational research · doi:10.1016/j.trsl.2014.03.002 · Cited by 10
Association of epigenetic landscapes with heterogeneity and plasticity in pancreatic cancer
Manoukian, P., Kuhnen, L. C., van Laarhoven, H. W. M., & Bijlsma, M. F. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104573 · Cited by 10
Lv, J., Qiao, H., Liu, H., Wu, X., Zhu, J., Su, J., Wang, F., Cui, Y., & Zhang, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014219 · Cited by 9
“In addition, advances in experimental approaches have enabled high-throughput sequencing and genome wide studies to identify epigenetically regulated patterns [26–32].”
BackgroundJiang, C. H., Hu, Y., Wang, S., & Chen, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1145067 · Cited by 9
“The epigenetic events would contribute to and investigate the underlying mechanisms of the pathogenesis of diabetes (25).”
BackgroundEpigenetic Alterations Are Associated With Gastric Emptying Disturbances in Diabetes Mellitus
Narayanan, S. P., Lee, J., Bhagwate, A. V., Kuwelker, S., Yan, H., Ördög, T., & Bharucha, A. E. (2020) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000136 · Cited by 6
Current approaches in CRISPR-Cas systems for diabetes
Arivarasan, V. K., Diwakar, D., Kamarudheen, N., & Karthik, L. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.08.002 · Cited by 9
Human aging in the post-GWAS era: further insights reveal potential regulatory variants
Haider, S. A., & Faisal, M. (2015) · Biogerontology · doi:10.1007/s10522-015-9575-y · Cited by 5
“2009) suggesting that different cells selectively activate particular regulatory regions of the genome in order to maintain their integrity (Bhandare et al. 2010).”
BackgroundLiver kinase B1 ( LKB1 ) regulates the epigenetic landscape of mouse pancreatic beta cells
Haberman, N., Cheung, R., Pizza, G., Cvetešić, N., Nagy, D., Maude, H., Blázquez, L., Lenhard, B., Cebola, I., Rutter, G. A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202401078r · Cited by 4
“28 In healthy human islets, only a minority of genes carry both marks simultaneously, including those associated with neuronal TFs. 63 Our previous work 6 demonstrated the loss of β - cell identity and increased expression in neuronal genes in LKB1 β KO islets.”
Shared genetic contribution to type 1 and type 2 diabetes riskPreprint
Aylward, A., Chiou, J., Okino, M.-L., Kadakia, N., & Gaulton, K. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/285304 · Cited by 4
Implications of noncoding regulatory functions in the development of insulinomas
Ramos-Rodríguez, M., Subirana-Granés, M., Norris, R., Sordi, V., Fernández, Á., Fuentes-Páez, G., Pérez-González, B., Balaguer, C. B., Raurell‐Vila, H., Chowdhury, M., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100604 · Cited by 3
“It is worth noting that the genomic distribution of the mutations may be driven by the tissue-specific chromatin landscape of the tumoral cell type of origin 37,38 and may not represent the result of a tu-moral-driven positive selection process.”
BackgroundCreating new β cells: cellular transmutation by genomic alchemy
Moss, L. G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68348 · Cited by 2
“Major inroads have been made into characterizing the transcriptional regulatory landscape of the genome in the context of whole islets (11–13).”
Epigenetic Modifications and Type 2 Diabetes in Humans
Ling, C. (2014) · Frontiers in diabetes · doi:10.1159/000362470 · Cited by 2
Metadata
- Authors
- Bhandare, R., Schug, J., Le Lay, J., Fox, A., Smirnova, O., Liu, C., Naji, A., & Kaestner, K. H.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-02-24
- Volume
- 20
- Issue
- 4
- Pages
- 428-433
- ISSN
- 1088-9051 (ISSN-L)
- PMC
- PMC2847745
- OpenAlex
- W2149952464
- Cited by
- 136
- References
- 27
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2023: 19 · 2022: 7 · 2021: 5 · 2020: 6 · 2019: 5 · 2018: 3 · 2017: 11 · 2016: 3 · 2015: 12 · 2014: 14 · 2013: 17 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genome Research (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- University of Pennsylvania
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 19525, DK R01-055342, R01DK055342, U01DK070430, P30DK019525)
- National Center for Research Resources (U42RR016600)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- histone modifications, pancreatic islets, type 2 diabetes, epigenetics, H3K4me1, H3K4me2, H3K4me3, H3K27me3, insulin gene, promoter structure, gene expression regulation, regulatory elements
- MeSH terms
- Histone Methyltransferases, Diabetes Mellitus, Type 2, Histones, Humans, Islets of Langerhans, Methylation, Promoter Regions, Genetic, Histone-Lysine N-Methyltransferase, Protein Processing, Post-Translational, Transcriptional Activation, CpG Islands, Polymorphism, Single Nucleotide, Gene Expression Profiling, Epigenesis, Genetic, Validation Studies as Topic, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
